TrialEuropean journal of nuclear medicine and molecular imaging2014

Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma.

Luigi Aloj et al.PubMed ↗Publisher ↗

No numbers read from the abstract.